 | • レポートコード：QY2108PAL8929 • 出版社/出版日：QYResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、146ページ • 納品方法：Eメール（納期：1日） • 産業分類：医薬品 |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の当調査資料ではグローバルにおける呼吸器用治療薬の市場規模（2016年-2027年）と動向についてまとめました。中国市場については主要プレイヤーの市場シェア、呼吸器用治療薬の種類別市場規模（吸入・点鼻薬、経口、その他）、用途別市場規模（病院、ドラッグストア）も掲載しています。他に、北米・アメリカ市場、ヨーロッパ市場、アジア太平洋・日本市場、中南米市場、中東・アフリカ市場の市場規模、グローバル市場機会・課題・リスク要因、バリューチェーン・販売チャネル、主要プレイヤーの情報なども掲載しています。 ・調査の概要 ・調査のサマリー ・世界の呼吸器用治療薬市場動向 ・グローバル主要プレイヤーの競争状況・市場シェア ・世界における呼吸器用治療薬の種類別市場規模（2016年-2027年）：吸入・点鼻薬、経口、その他 ・世界における呼吸器用治療薬の用途別市場規模（2016年-2027年）：病院、ドラッグストア ・呼吸器用治療薬の中国市場分析 - 呼吸器用治療薬の中国市場規模（2016年-2027年） - 中国における呼吸器用治療薬の主要プレイヤー別市場シェア - 中国における呼吸器用治療薬の種類別市場規模：吸入・点鼻薬、経口、その他 - 中国における呼吸器用治療薬の用途別市場規模：病院、ドラッグストア ・呼吸器用治療薬の北米市場（2016年-2027年） ・呼吸器用治療薬のヨーロッパ市場（2016年-2027年） ・呼吸器用治療薬のアジア太平洋市場（2016年-2027年） ・呼吸器用治療薬の中南米市場（2016年-2027年） ・呼吸器用治療薬の中東・アフリカ市場（2016年-2027年） ・主要プレイヤーの情報：GSK、AstraZeneca、Boehringer Ingelheim、Vertex、Roche、Novartis、Teva、Chiesi、Mylan、Sumitomo Dainippon、Merck、Beximco ・市場機会・課題・リスク要因分析 ・バリューチェーン・販売チャネル分析 ・... |
Respiratory drug is a term used to describe a wide variety of medicines used to relieve, treat, or prevent respiratory diseases such as asthma, chronic bronchitis, chronic obstructive pulmonary disease (COPD), or pneumonia.
The classification of Respiratory Drug includes Inhalable & Nasal Spray, Oral and Others, and the proportion of Inhalable & Nasal Spray in 2019 is about 68.82%.
Respiratory Drug widely sold through Hospital and Drugs Store. The most proportion of Respiratory Drug sold through Drugs Store, and the proportion in 2019 is 58.28%.
North America is the largest consumption place, with a consumption market share nearly 35.24% in 2019. Following North America, Europe is the second largest consumption place with the consumption market share of 28.58%. Moreover, the Asian market is expected to register the highest CAGR during the forecast period.
Market competition is intense. GSK, AstraZeneca, Boehringer Ingelheim, Vertex, Roche, etc. are the leaders of the industry.
Market Analysis and Insights: Global and China Respiratory Drug Market
This report focuses on global and China Respiratory Drug market.
In 2020, the global Respiratory Drug market size was US$ 40630 million and it is expected to reach US$ 60360 million by the end of 2027, with a CAGR of 5.8% during 2021-2027. In China the Respiratory Drug market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.
Global Respiratory Drug Scope and Market Size
Respiratory Drug market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Respiratory Drug market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For China market, this report focuses on the Respiratory Drug market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in China.
Segment by Type
Inhalable & Nasal Spray
Oral
Others
Segment by Application
Hospital
Drugs Store
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
GSK
AstraZeneca
Boehringer Ingelheim
Vertex
Roche
Novartis
Teva
Chiesi
Mylan
Sumitomo Dainippon
Merck
Beximco
1 Study Coverage
1.1 Respiratory Drug Product Introduction
1.2 Market by Type
1.2.1 Global Respiratory Drug Market Size Growth Rate by Type
1.2.2 Inhalable & Nasal Spray
1.2.3 Oral
1.2.4 Others
1.3 Market by Application
1.3.1 Global Respiratory Drug Market Size Growth Rate by Application
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Respiratory Drug Market Size, Estimates and Forecasts
2.1.1 Global Respiratory Drug Revenue 2016-2027
2.1.2 Global Respiratory Drug Sales 2016-2027
2.2 Global Respiratory Drug, Market Size by Region: 2016 VS 2021 VS 2027
2.3 Respiratory Drug Historical Market Size by Region (2016-2021)
2.3.1 Global Respiratory Drug Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global Respiratory Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 Respiratory Drug Market Estimates and Projections by Region (2022-2027)
2.4.1 Global Respiratory Drug Sales Forecast by Region (2022-2027)
2.4.2 Global Respiratory Drug Revenue Forecast by Region (2022-2027)
3 Global Respiratory Drug Competitor Landscape by Players
3.1 Global Top Respiratory Drug Manufacturers by Sales
3.1.1 Global Respiratory Drug Sales by Manufacturer (2016-2021)
3.1.2 Global Respiratory Drug Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top Respiratory Drug Manufacturers by Revenue
3.2.1 Key Respiratory Drug Manufacturers Covered: Ranking by Revenue
3.2.2 Global Respiratory Drug Revenue by Manufacturers (2016-2021)
3.2.3 Global Respiratory Drug Revenue Share by Manufacturers (2016-2021)
3.2.4 Global Respiratory Drug Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by Respiratory Drug Revenue in 2020
3.2.6 Global Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global Respiratory Drug Price by Manufacturers
3.4 Global Respiratory Drug Manufacturing Base Distribution, Product Types
3.4.1 Respiratory Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Respiratory Drug Product Type
3.4.3 Date of International Manufacturers Enter into Respiratory Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global Respiratory Drug Market Size by Type (2016-2021)
4.1.1 Global Respiratory Drug Sales by Type (2016-2021)
4.1.2 Global Respiratory Drug Revenue by Type (2016-2021)
4.1.3 Respiratory Drug Average Selling Price (ASP) by Type (2016-2021)
4.2 Global Respiratory Drug Market Size Forecast by Type (2022-2027)
4.2.1 Global Respiratory Drug Sales Forecast by Type (2022-2027)
4.2.2 Global Respiratory Drug Revenue Forecast by Type (2022-2027)
4.2.3 Respiratory Drug Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global Respiratory Drug Market Size by Application (2016-2021)
5.1.1 Global Respiratory Drug Sales by Application (2016-2021)
5.1.2 Global Respiratory Drug Revenue by Application (2016-2021)
5.1.3 Respiratory Drug Price by Application (2016-2021)
5.2 Respiratory Drug Market Size Forecast by Application (2022-2027)
5.2.1 Global Respiratory Drug Sales Forecast by Application (2022-2027)
5.2.2 Global Respiratory Drug Revenue Forecast by Application (2022-2027)
5.2.3 Global Respiratory Drug Price Forecast by Application (2022-2027)
6 China by Players, Type and Application
6.1 China Respiratory Drug Market Size YoY Growth 2016-2027
6.1.1 China Respiratory Drug Sales YoY Growth 2016-2027
6.1.2 China Respiratory Drug Revenue YoY Growth 2016-2027
6.1.3 China Respiratory Drug Market Share in Global Market 2016-2027
6.2 China Respiratory Drug Market Size by Players (International and Local Players)
6.2.1 China Top Respiratory Drug Players by Sales (2016-2021)
6.2.2 China Top Respiratory Drug Players by Revenue (2016-2021)
6.3 China Respiratory Drug Historic Market Review by Type (2016-2021)
6.3.1 China Respiratory Drug Sales Market Share by Type (2016-2021)
6.3.2 China Respiratory Drug Revenue Market Share by Type (2016-2021)
6.3.3 China Respiratory Drug Price by Type (2016-2021)
6.4 China Respiratory Drug Market Estimates and Forecasts by Type (2022-2027)
6.4.1 China Respiratory Drug Sales Forecast by Type (2022-2027)
6.4.2 China Respiratory Drug Revenue Forecast by Type (2022-2027)
6.4.3 China Respiratory Drug Price Forecast by Type (2022-2027)
6.5 China Respiratory Drug Historic Market Review by Application (2016-2021)
6.5.1 China Respiratory Drug Sales Market Share by Application (2016-2021)
6.5.2 China Respiratory Drug Revenue Market Share by Application (2016-2021)
6.5.3 China Respiratory Drug Price by Application (2016-2021)
6.6 China Respiratory Drug Market Estimates and Forecasts by Application (2022-2027)
6.6.1 China Respiratory Drug Sales Forecast by Application (2022-2027)
6.6.2 China Respiratory Drug Revenue Forecast by Application (2022-2027)
6.6.3 China Respiratory Drug Price Forecast by Application (2022-2027)
7 North America
7.1 North America Respiratory Drug Market Size YoY Growth 2016-2027
7.2 North America Respiratory Drug Market Facts & Figures by Country
7.2.1 North America Respiratory Drug Sales by Country (2016-2021)
7.2.2 North America Respiratory Drug Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific Respiratory Drug Market Size YoY Growth 2016-2027
8.2 Asia Pacific Respiratory Drug Market Facts & Figures by Region
8.2.1 Asia Pacific Respiratory Drug Sales by Region (2016-2021)
8.2.2 Asia Pacific Respiratory Drug Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe Respiratory Drug Market Size YoY Growth 2016-2027
9.2 Europe Respiratory Drug Market Facts & Figures by Country
9.2.1 Europe Respiratory Drug Sales by Country (2016-2021)
9.2.2 Europe Respiratory Drug Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America Respiratory Drug Market Size YoY Growth 2016-2027
10.2 Latin America Respiratory Drug Market Facts & Figures by Country
10.2.1 Latin America Respiratory Drug Sales by Country (2016-2021)
10.2.2 Latin America Respiratory Drug Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Respiratory Drug Market Size YoY Growth 2016-2027
11.2 Middle East and Africa Respiratory Drug Market Facts & Figures by Country
11.2.1 Middle East and Africa Respiratory Drug Sales by Country (2016-2021)
11.2.2 Middle East and Africa Respiratory Drug Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Description and Business Overview
12.1.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.1.4 GSK Respiratory Drug Products Offered
12.1.5 GSK Recent Development
12.2 AstraZeneca
12.2.1 AstraZeneca Corporation Information
12.2.2 AstraZeneca Description and Business Overview
12.2.3 AstraZeneca Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.2.4 AstraZeneca Respiratory Drug Products Offered
12.2.5 AstraZeneca Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Description and Business Overview
12.3.3 Boehringer Ingelheim Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Boehringer Ingelheim Respiratory Drug Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Vertex
12.4.1 Vertex Corporation Information
12.4.2 Vertex Description and Business Overview
12.4.3 Vertex Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Vertex Respiratory Drug Products Offered
12.4.5 Vertex Recent Development
12.5 Roche
12.5.1 Roche Corporation Information
12.5.2 Roche Description and Business Overview
12.5.3 Roche Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Roche Respiratory Drug Products Offered
12.5.5 Roche Recent Development
12.6 Novartis
12.6.1 Novartis Corporation Information
12.6.2 Novartis Description and Business Overview
12.6.3 Novartis Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Novartis Respiratory Drug Products Offered
12.6.5 Novartis Recent Development
12.7 Teva
12.7.1 Teva Corporation Information
12.7.2 Teva Description and Business Overview
12.7.3 Teva Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Teva Respiratory Drug Products Offered
12.7.5 Teva Recent Development
12.8 Chiesi
12.8.1 Chiesi Corporation Information
12.8.2 Chiesi Description and Business Overview
12.8.3 Chiesi Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Chiesi Respiratory Drug Products Offered
12.8.5 Chiesi Recent Development
12.9 Mylan
12.9.1 Mylan Corporation Information
12.9.2 Mylan Description and Business Overview
12.9.3 Mylan Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Mylan Respiratory Drug Products Offered
12.9.5 Mylan Recent Development
12.10 Sumitomo Dainippon
12.10.1 Sumitomo Dainippon Corporation Information
12.10.2 Sumitomo Dainippon Description and Business Overview
12.10.3 Sumitomo Dainippon Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Sumitomo Dainippon Respiratory Drug Products Offered
12.10.5 Sumitomo Dainippon Recent Development
12.11 GSK
12.11.1 GSK Corporation Information
12.11.2 GSK Description and Business Overview
12.11.3 GSK Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.11.4 GSK Respiratory Drug Products Offered
12.11.5 GSK Recent Development
12.12 Beximco
12.12.1 Beximco Corporation Information
12.12.2 Beximco Description and Business Overview
12.12.3 Beximco Respiratory Drug Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Beximco Products Offered
12.12.5 Beximco Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Respiratory Drug Industry Trends
13.2 Respiratory Drug Market Drivers
13.3 Respiratory Drug Market Challenges
13.4 Respiratory Drug Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Respiratory Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Global Respiratory Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Inhalable & Nasal Spray
Table 3. Major Manufacturers of Oral
Table 4. Major Manufacturers of Others
Table 5. Global Respiratory Drug Market Size Growth Rate by Application (2021-2027) & (M Units)
Table 6. Global Respiratory Drug Market Size by Region (M Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 7. Global Respiratory Drug Sales by Regions (2016-2021) & (M Units)
Table 8. Global Respiratory Drug Sales Market Share by Regions (2016-2021)
Table 9. Global Respiratory Drug Revenue by Regions (2016-2021) & (US$ Million)
Table 10. Global Respiratory Drug Sales Forecast by Region (2022-2027) & (M Units)
Table 11. Global Respiratory Drug Sales Market Share Forecast by Region (2022-2027)
Table 12. Global Respiratory Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 13. Global Respiratory Drug Revenue Market Share Forecast by Region (2022-2027)
Table 14. Global Respiratory Drug Sales by Manufacturers (2016-2021) (M Units)
Table 15. Global Respiratory Drug Sales Share by Manufacturers (2016-2021)
Table 16. Ranking of Global Top Respiratory Drug Manufacturers by Revenue (US$ Million) in 2020
Table 17. Respiratory Drug Revenue by Manufacturers (2016-2021) (US$ Million)
Table 18. Respiratory Drug Revenue Share by Manufacturers (2016-2021)
Table 19. Global Respiratory Drug Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 20. Global Respiratory Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Respiratory Drug as of 2020)
Table 21. Key Manufacturers Respiratory Drug Price (2016-2021) (US$/Unit)
Table 22. Respiratory Drug Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Respiratory Drug Product Type
Table 24. Date of International Manufacturers Enter into Respiratory Drug Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Global Respiratory Drug Sales by Type (2016-2021) (M Units)
Table 27. Global Respiratory Drug Sales Share by Type (2016-2021)
Table 28. Global Respiratory Drug Revenue by Type (2016-2021) (US$ Million)
Table 29. Global Respiratory Drug Revenue Share by Type (2016-2021)
Table 30. Respiratory Drug Average Selling Price (ASP) by Type (2016-2021) & (US$/Unit)
Table 31. Global Respiratory Drug Sales Forecast by Type (2022-2027) & (M Units)
Table 32. Global Respiratory Drug Sales Market Share Forecast by Type (2022-2027)
Table 33. Global Respiratory Drug Revenue Forecast V (2022-2027) & (US$ Million)
Table 34. Global Respiratory Drug Revenue Market Share Forecast by Type (2022-2027)
Table 35. Global Respiratory Drug Average Selling Price (ASP) Forecast by Type (2022-2027) & (US$/Unit)
Table 36. Global Respiratory Drug Sales by Application (2016-2021) (M Units)
Table 37. Global Respiratory Drug Sales Share by Application (2016-2021)
Table 38. Global Respiratory Drug Revenue by Application (2016-2021) (US$ Million)
Table 39. Global Respiratory Drug Revenue Share by Application (2016-2021)
Table 40. Respiratory Drug Average Selling Price (ASP) by Application (2016-2021) & (US$/Unit)
Table 41. Global Respiratory Drug Sales Forecast by Application (2022-2027) & (M Units)
Table 42. Global Respiratory Drug Sales Market Share Forecast by Application (2022-2027)
Table 43. Global Respiratory Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 44. Global Respiratory Drug Revenue Market Share Forecast by Application (2022-2027)
Table 45. Global Respiratory Drug Average Selling Price (ASP) Forecast by Application (2022-2027) & (US$/Unit)
Table 46. China Respiratory Drug Sales (M Units) of Key Companies (2016-2021)
Table 47. China Respiratory Drug Sales Share by Company (2016-2021)
Table 48. China Respiratory Drug Revenue (US$ Million) by Company (2016-2021)
Table 49. China Respiratory Drug Revenue Share by Company (2016-2021)
Table 50. China Respiratory Drug Sales (M Units) by Type (2016-2021)
Table 51. China Respiratory Drug Sales Share by Type (2016-2021)
Table 52. China Respiratory Drug Revenue (US$ Million) Market Share by Type (2016-2021)
Table 53. China Respiratory Drug Price (US$/Unit) by Type (2016-2021)
Table 54. China Respiratory Drug Sales (M Units) by Type (2022-2027)
Table 55. China Respiratory Drug Sales Share by Type (2022-2027)
Table 56. China Respiratory Drug Revenue (US$ Million) Market Share by Type (2022-2027)
Table 57. China Respiratory Drug Revenue Share by Type (2022-2027)
Table 58. China Respiratory Drug Price (US$/Unit) by Type (2022-2027)
Table 59. China Respiratory Drug Sales (M Units) by Application (2016-2021)
Table 60. China Respiratory Drug Sales Share by Application (2016-2021)
Table 61. China Respiratory Drug Revenue (US$ Million) Market Share by Application (2016-2021)
Table 62. China Respiratory Drug Price (US$/Unit) by Application (2016-2021)
Table 63. China Respiratory Drug Sales (M Units) by Application (2022-2027)
Table 64. China Respiratory Drug Sales Share by Application (2022-2027)
Table 65. China Respiratory Drug Revenue (US$ Million) Market Share by Application (2022-2027)
Table 66. China Respiratory Drug Revenue Share by Application (2022-2027)
Table 67. China Respiratory Drug Price (US$/Unit) by Application (2022-2027)
Table 68. North America Respiratory Drug Sales by Country (2016-2021) & (M Units)
Table 69. North America Respiratory Drug Sales Market Share by Country (2016-2021)
Table 70. North America Respiratory Drug Revenue by Country (2016-2021) & (US$ Million)
Table 71. North America Respiratory Drug Revenue Market Share by Country (2016-2021)
Table 72. Asia Pacific Respiratory Drug Sales by Region (2016-2021) & (M Units)
Table 73. Asia Pacific Respiratory Drug Sales Market Share by Region (2016-2021)
Table 74. Asia Pacific Respiratory Drug Revenue by Region (2016-2021) & (US$ Million)
Table 75. Asia Pacific Respiratory Drug Revenue Market Share by Region (2016-2021)
Table 76. Europe Respiratory Drug Sales by Country (2016-2021) & (M Units)
Table 77. Europe Respiratory Drug Sales Market Share by Country (2016-2021)
Table 78. Europe Respiratory Drug Revenue by Country (2016-2021) & (US$ Million)
Table 79. Europe Respiratory Drug Revenue Market Share by Country (2016-2021)
Table 80. Latin America Respiratory Drug Sales by Country (2016-2021) & (M Units)
Table 81. Latin America Respiratory Drug Sales Market Share by Country (2016-2021)
Table 82. Latin Americaa Respiratory Drug Revenue by Country (2016-2021) & (US$ Million)
Table 83. Latin America Respiratory Drug Revenue Market Share by Country (2016-2021)
Table 84. Middle East and Africa Respiratory Drug Sales by Country (2016-2021) & (M Units)
Table 85. Middle East and Africa Respiratory Drug Sales Market Share by Country (2016-2021)
Table 86. Middle East and Africa Respiratory Drug Revenue by Country (2016-2021) & (US$ Million)
Table 87. Middle East and Africa Respiratory Drug Revenue Market Share by Country (2016-2021)
Table 88. GSK Corporation Information
Table 89. GSK Description and Business Overview
Table 90. GSK Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. GSK Respiratory Drug Product
Table 92. GSK Recent Development
Table 93. AstraZeneca Corporation Information
Table 94. AstraZeneca Description and Business Overview
Table 95. AstraZeneca Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 96. AstraZeneca Product
Table 97. AstraZeneca Recent Development
Table 98. Boehringer Ingelheim Corporation Information
Table 99. Boehringer Ingelheim Description and Business Overview
Table 100. Boehringer Ingelheim Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 101. Boehringer Ingelheim Product
Table 102. Boehringer Ingelheim Recent Development
Table 103. Vertex Corporation Information
Table 104. Vertex Description and Business Overview
Table 105. Vertex Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 106. Vertex Product
Table 107. Vertex Recent Development
Table 108. Roche Corporation Information
Table 109. Roche Description and Business Overview
Table 110. Roche Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 111. Roche Product
Table 112. Roche Recent Development
Table 113. Novartis Corporation Information
Table 114. Novartis Description and Business Overview
Table 115. Novartis Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 116. Novartis Product
Table 117. Novartis Recent Development
Table 118. Teva Corporation Information
Table 119. Teva Description and Business Overview
Table 120. Teva Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 121. Teva Product
Table 122. Teva Recent Development
Table 123. Chiesi Corporation Information
Table 124. Chiesi Description and Business Overview
Table 125. Chiesi Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 126. Chiesi Product
Table 127. Chiesi Recent Development
Table 128. Mylan Corporation Information
Table 129. Mylan Description and Business Overview
Table 130. Mylan Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 131. Mylan Product
Table 132. Mylan Recent Development
Table 133. Sumitomo Dainippon Corporation Information
Table 134. Sumitomo Dainippon Description and Business Overview
Table 135. Sumitomo Dainippon Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 136. Sumitomo Dainippon Product
Table 137. Sumitomo Dainippon Recent Development
Table 138. Merck Corporation Information
Table 139. Merck Description and Business Overview
Table 140. Merck Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 141. Merck Product
Table 142. Merck Recent Development
Table 143. Beximco Corporation Information
Table 144. Beximco Description and Business Overview
Table 145. Beximco Respiratory Drug Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2016-2021)
Table 146. Beximco Product
Table 147. Beximco Recent Development
Table 148. Respiratory Drug Market Trends
Table 149. Respiratory Drug Market Drivers
Table 150. Respiratory Drug Market Challenges
Table 151. Respiratory Drug Market Restraints
Table 152. Respiratory Drug Customers List
Table 153. Respiratory Drug Distributors List
Table 154. Research Programs/Design for This Report
Table 155. Key Data Information from Secondary Sources
Table 156. Key Data Information from Primary Sources
List of Figures
Figure 1. Respiratory Drug Product Picture
Figure 2. Global Respiratory Drug Sales Market Share by Type in 2020 & 2027
Figure 3. Inhalable & Nasal Spray Product Picture
Figure 4. Oral Product Picture
Figure 5. Others Product Picture
Figure 6. Global Respiratory Drug Sales Market Share by Application in 2020 & 2027
Figure 7. Hospital
Figure 8. Drugs Store
Figure 9. Respiratory Drug Report Years Considered
Figure 10. Global Respiratory Drug Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Respiratory Drug Market Size 2016-2027 (US$ Million)
Figure 12. Global Respiratory Drug Sales 2016-2027 (M Units)
Figure 13. Global Respiratory Drug Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global Respiratory Drug Sales Market Share by Region (2016-2021)
Figure 15. Global Respiratory Drug Sales Market Share by Region in 2020
Figure 16. Global Respiratory Drug Revenue Market Share by Region (2016-2021)
Figure 17. Global Respiratory Drug Revenue Market Share by Region in 2020
Figure 18. Global Respiratory Drug Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by Respiratory Drug Revenue in 2020
Figure 20. Respiratory Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global Respiratory Drug Sales Market Share by Type (2016-2021)
Figure 22. Global Respiratory Drug Sales Market Share by Type in 2020
Figure 23. Global Respiratory Drug Revenue Market Share by Type (2016-2021)
Figure 24. Global Respiratory Drug Revenue Market Share by Type in 2020
Figure 25. Global Respiratory Drug Sales Market Share by Application (2016-2021)
Figure 26. Global Respiratory Drug Sales Market Share by Application in 2020
Figure 27. Global Respiratory Drug Revenue Market Share by Application (2016-2021)
Figure 28. Global Respiratory Drug Revenue Market Share by Application in 2020
Figure 29. China Respiratory Drug Sales Growth Rate 2016-2027 (M Units)
Figure 30. China Respiratory Drug Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. China Respiratory Drug Market Share in Global Market 2016-2027
Figure 32. China 5 and 10 Largest Respiratory Drug Players Market Share by Revenue in Respiratory Drug in 2020
Figure 33. China Respiratory Drug Revenue Share by Type (2016-2021)
Figure 34. China Respiratory Drug Revenue Growth Rate by Type in 2016 & 2020
Figure 35. China Respiratory Drug Revenue Share by Application (2016-2021)
Figure 36. China Respiratory Drug Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America Respiratory Drug Sales Growth Rate 2016-2021 (M Units)
Figure 38. North America Respiratory Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America Respiratory Drug Sales Market Share by Country in 2020
Figure 40. North America Respiratory Drug Revenue Market Share by Country in 2020
Figure 41. U.S. Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 42. U.S. Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 44. Canada Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe Respiratory Drug Sales Growth Rate 2016-2021 (M Units)
Figure 46. Europe Respiratory Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe Respiratory Drug Sales Market Share by Country in 2020
Figure 48. Europe Respiratory Drug Revenue Market Share by Country in 2020
Figure 49. Germany Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 50. Germany Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 52. France Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 54. U.K. Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 56. Italy Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 58. Russia Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific Respiratory Drug Sales Growth Rate 2016-2021 (M Units)
Figure 60. Asia Pacific Respiratory Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific Respiratory Drug Sales Market Share by Region in 2020
Figure 62. Asia Pacific Respiratory Drug Revenue Market Share by Region in 2020
Figure 63. China Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 64. China Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 66. Japan Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 68. South Korea Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 70. India Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 72. Australia Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 74. Taiwan Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 76. Indonesia Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 78. Thailand Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 80. Malaysia Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 82. Philippines Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 84. Vietnam Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America Respiratory Drug Sales Growth Rate 2016-2021 (M Units)
Figure 86. Latin America Respiratory Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America Respiratory Drug Sales Market Share by Country in 2020
Figure 88. Latin America Respiratory Drug Revenue Market Share by Country in 2020
Figure 89. Mexico Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 90. Mexico Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 92. Brazil Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 94. Argentina Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa Respiratory Drug Sales Growth Rate 2016-2021 (M Units)
Figure 96. Middle East and Africa Respiratory Drug Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa Respiratory Drug Sales Market Share by Country in 2020
Figure 98. Middle East and Africa Respiratory Drug Revenue Market Share by Country in 2020
Figure 99. Turkey Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 100. Turkey Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 102. Saudi Arabia Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE Respiratory Drug Sales Growth Rate (2016-2021) (M Units)
Figure 104. UAE Respiratory Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. Respiratory Drug Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
処方用呼吸器治療薬の世界市場 2020年 Market Overview The global Prescription Respiratory Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Prescription R…- 世界の心肺ストレステスト機器市場インサイト・予測（～2027年） Market Analysis and Insights: Global Cardio-respiratory Stress Test Equipment Market The global Cardio-respiratory Stress Test Equipment market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Cardio-…
- 世界の心肺ストレステスト機器市場インサイト・予測（～2027年） Market Analysis and Insights: Global Cardio-respiratory Stress Test Equipment Market The global Cardio-respiratory Stress Test Equipment market is valued at US$ XX million in 2020. The market size will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2021-2027. Global Cardio-…
- 市販薬の世界市場 2020年 Market Overview The global Over-the-Counter Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Over-the-Counter Drug m…
- 呼吸用保護具（RPE）の世界市場 2020年 Market Overview The Respiratory Protective Equipment (RPE) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value ch…